Level Zero Health Raises £5.5M for Hormone Tracking

Level Zero Health is pioneering new tech.

What’s happening: The biosensor startup added £5.5M ($6.9M) in a pre-seed round to develop a continuous hormone monitoring wearable.

Replacing blood draws, its microneedle patch is undergoing clinical efficacy trials, with use cases supporting women’s IVF journeys, men’s TRT treatment, and more.

Missing link. Modulating nearly every bodily function, hormonal health is underrepresented in personalized well-being plans, especially for women.

As adoption of continuous glucose monitors (CGMs) unlocks health insights beyond diabetes, Level Zero hopes for a similar trajectory, translating progesterone, estrogen, and testosterone levels to real-time management.

Honors chem. Not alone, from Mira’s at-home pod to Eli Health’s “hormometer” to Persperity Health’s microfluidic patch, hormonal healthtech companies are analyzing urine, saliva, and sweat to provide personalized insights.

Looking ahead: With levels shifting through life, continuous hormone monitors (CHMs) represent a breakthrough for men and women optimizing their well-being.